ALLOGENE THERAPEUTICS INC. - COMMON STOCK
1.4400
04-April-25 16:45:00
15 minutes delayed
Stocks
+0.0600
+4.35%
Today's range
1.3200 - 1.4600
ISIN
N/A
Source
NASDAQ
-
13 Mar 2025 16:02:00 By Nasdaq GlobeNewswire
-
03 Mar 2025 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in March Investor Conference
26 Feb 2025 08:30:00 By Nasdaq GlobeNewswire
-
25 Feb 2025 16:10:07 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in February Investor Conferences
04 Feb 2025 08:30:00 By Nasdaq GlobeNewswire
-
29 Jan 2025 08:30:00 By Nasdaq GlobeNewswire
-
28 Jan 2025 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
16 Dec 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Acknowledges the Passing of Founding Board Member David Bonderman
12 Dec 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in December Investor Conferences
19 Nov 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
07 Nov 2024 16:02:00 By Nasdaq GlobeNewswire
-
07 Nov 2024 10:00:00 By Nasdaq GlobeNewswire
-
05 Nov 2024 09:10:30 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in November Investor Conferences
04 Nov 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update
30 Oct 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference
30 Sep 2024 08:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >